Cyxone Ab Stock Net Asset
| CYXO Stock | SEK 0.03 0.01 21.57% |
Cyxone AB fundamentals help investors to digest information that contributes to Cyxone AB's financial success or failures. It also enables traders to predict the movement of Cyxone Stock. The fundamental analysis module provides a way to measure Cyxone AB's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cyxone AB stock.
Cyxone |
Cyxone AB Company Net Asset Analysis
Cyxone AB's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Cyxone AB Net Asset | 46.13 M |
Most of Cyxone AB's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cyxone AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Based on the recorded statements, Cyxone AB has a Net Asset of 46.13 M. This is much higher than that of the Healthcare sector and significantly higher than that of the Biotechnology industry. The net asset for all Sweden stocks is notably lower than that of the firm.
Cyxone Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cyxone AB's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cyxone AB could also be used in its relative valuation, which is a method of valuing Cyxone AB by comparing valuation metrics of similar companies.Cyxone AB is currently under evaluation in net asset category among its peers.
Cyxone Fundamentals
| Return On Equity | -1.07 | |||
| Return On Asset | -0.59 | |||
| Current Valuation | 7.74 M | |||
| Shares Outstanding | 98.44 M | |||
| Shares Owned By Insiders | 25.38 % | |||
| Price To Book | 1.00 X | |||
| Price To Sales | 5,168 X | |||
| EBITDA | (43.23 M) | |||
| Net Income | (45.03 M) | |||
| Cash And Equivalents | 56.34 M | |||
| Cash Per Share | 0.97 X | |||
| Current Ratio | 11.35 X | |||
| Book Value Per Share | 0.50 X | |||
| Cash Flow From Operations | (43.25 M) | |||
| Earnings Per Share | (0.76) X | |||
| Target Price | 4.2 | |||
| Beta | 0.54 | |||
| Market Capitalization | 52.96 M | |||
| Total Asset | 46.13 M | |||
| Net Asset | 46.13 M |
About Cyxone AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cyxone AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cyxone AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cyxone AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cyxone Stock Analysis
When running Cyxone AB's price analysis, check to measure Cyxone AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyxone AB is operating at the current time. Most of Cyxone AB's value examination focuses on studying past and present price action to predict the probability of Cyxone AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyxone AB's price. Additionally, you may evaluate how the addition of Cyxone AB to your portfolios can decrease your overall portfolio volatility.